In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 231 for your search:
Drug:  thioguanine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 60
Sponsor:
Protocol IDs: NCI-D81-018-590, DFCI-80035

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4273

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 17
Sponsor:
Protocol IDs: GER-GPOH-AML-BFM-93, EU-93008

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-9421

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to physiologic 59
Sponsor: Other
Protocol IDs: MRC-LEUK-AML12, EU-95001, NCT00002658

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-06952, ITA-GIMEMA-AIEOP-1, NCT00002701

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: CDR0000064665, CCG-1952, NCT00002744

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 1961, CCG-1961, CDR0000064953, NCT00002812

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 10
Sponsor: NCI, Other
Protocol IDs: A9952, CCG-A9952, POG-A9952, CCG-9952, CDR0000065394, COG-A9952, NCT00002944

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 15
Sponsor:
Protocol IDs: UKCCSG-NHL-9503, EU-98012, NCT00003423

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: Other
Protocol IDs: MRC-LEUK-ALL97, EU-97032, NCT00003437

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: A2971, COG-A2971, CCG-A2971, POG-A2971, CCG-29701, CDR0000066664, NCT00003593

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: A5971, CCG-59701, CCG-59701C, CCG-A5971, POG-A5971, CDR0000067470, COG-A5971, NCT00004228

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 9904, COG-P9904, POG-9904, CDR0000067657, NCI-2012-02321, NCT00005585

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: 9905, COG-P9905, POG-9905, CDR0000067704, NCI-2012-02325, NCT00005596
1     
New Search